Hui Wei, MD

Trials

Studies that name Hui Wei, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:07 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07132684 · Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

  Institute of Hematology & Blood Diseases Hospital, China · recruiting · AML, Adult · principal investigator
• N/A
  NCT06991920 · Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage

  Institute of Hematology & Blood Diseases Hospital, China · not yet recruiting · Adult ALL, MPAL · principal investigator
• Ph2
  NCT06635681 · Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML

  Institute of Hematology & Blood Diseases Hospital, China · recruiting · AML (Acute Myelogenous Leukemia) · principal investigator
• Ph1/Ph2
  NCT06611839 · Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML

  Institute of Hematology & Blood Diseases Hospital, China · recruiting · AML, IDH1 Mutation, Treatment · principal investigator
• N/A
  NCT06529250 · Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

  Institute of Hematology & Blood Diseases Hospital, China · recruiting · AML · principal investigator
• N/A
  NCT06066242 · Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy

  Institute of Hematology & Blood Diseases Hospital, China · active not recruiting · Acute Myeloid Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.